Giuseppe Cullaro, MD

Transplant Hepatology
Gastroenterology
Accepting New Patients
Virtual Visits/Telehealth

On the web

Profile Headshot

Profile Navigation

Overview

Giuseppe Cullaro, MD, is a gastroenterologist and transplant hepatologist who cares for patients with general hepatology and transplant hepatology needs.

His academic interests lie at the intersection of hepatology and nephrology. Specifically, he focuses on improving outcomes for patients with end-stage liver disease by identifying predictive markers of future kidney dysfunction—markers that may inform the mechanism of disease pathogenesis and allow for the implementation of preventative strategies.

Dr. Cullaro earned his undergraduate and medical degrees from Boston University. He completed a residency in Internal Medicine at New York Presbyterian—Columbia University, followed by a gastroenterology fellowship at UCSF and a transplant hepatology fellowship at New York Presbyterian—Cornell and Columbia University in 2020. In 2019, he obtained a Master of Advanced Studies in Clinical Research through the UCSF Graduate Division.

Academic Appointments

  • Assistant Professor of Medicine at CUIMC

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:
212-305-0914

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

CUIMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
New York, NY 10032
Primary
Phone:
212-305-0914
Open location in Google Maps

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AmeriHealth of New Jersey

  • PPO - New Jersey Services

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Horizon Blue Cross Blue Shield

  • EPO - New Jersey Services
  • HMO - New Jersey Services
  • New Jersey Services (Medicaid Managed Care)
  • POS - New Jersey Services
  • PPO - New Jersey Services

Local 1199

  • Local 1199
  • NYP Employee Plan

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

QualCare

  • HMO - New Jersey Services
  • POS - New Jersey Services
  • PPO - New Jersey Services

RiverSpring

  • Special Needs

TRICARE

  • TRICARE

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care
  • New Jersey Services (Medicare Managed Care)

World Trade Center Health Plan

  • World Trade Center Health Plan

*Before your appointment, please contact the doctor’s office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.

Credentials & Experience

Education & Training

  • BS, 2009 Biochemistry and Molecular Biology, Boston University
  • MD, 2013 Boston University School of Medicine
  • MAS, 2019 Clinical Research, University of California, San Francisco (UCSF)
  • Residency: 2016 NewYork-Presbyterian / Columbia University Irving Medical Center
  • Fellowship: 2019 University of California, San Francisco (UCSF)
  • Fellowship: 2020 NewYork-Presbyterian / Columbia University Irving Medical Center

Board Certifications

  • Transplant Hepatology
  • Gastroenterology

Honors & Awards

  • NIDDK K23 Career Development Award, 2023
  • AASLD Presidential Poster of Distinction, 2023
  • UCSF Liver Center Pilot Award, 2021
  • AASLD Clinical, Translational, and Outcomes Research Award, 2021
  • ATC Young Investigator Award, 2019
  • AASLD Foundation Advanced/Transplant Hepatology Award, 2019
  • AASLD Early Career Investigator Award in Clinical/Translational Science, 2019
  • ATC Poster of Distinction, 2018
  • ACG GI Jeopardy Champion, 2017
  • House Staff Teaching Award, 2015
  • AASLD Presidential Poster of Distinction, 2014
  • Alpha Omega Alpha (AOA), 2013
  • Internal Medicine Award, 2013
  • Scholar Athlete, America East Conference, 2008

Research

Selected Publications

  1. Cullaro, G., Allegretti, A. S., Patidar, K. R., Verna, E. C. & Lai, J. C. Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among decompensated cirrhosis patients. Liver Transplantation 10.1097/LVT.0000000000000439.
  2. Cama-Olivares, A. et al. Association of HRS-AKI with mortality in patients with cirrhosis requiring renal replacement therapy: Results from the HRS-HARMONY consortium: Results from the HRS-HARMONY consortium. Kidney360 (2024) doi:10.34067/KID.0000000589.
  3. Lai, M., Lai, J. C., Allegretti, A. S., Patidar, K. R. & Cullaro, G. Investigating the association between steatotic liver disease and CKD in a nationally representative sample. Kidney360 (2024) doi:10.34067/KID.0000000569.
  4. Li, X. et al. Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 30, 1106–1115 (2024).
  5. Ma, A. T. et al. Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment. Pharmacol. Ther. (2024) doi:10.1111/apt.18159.
  6. Fallahzadeh, M. A. et al. Performance of race-neutral eGFR equations in patients with decompensated cirrhosis. Liver Transpl. 10.1097/LVT.0000000000000410 (2024).
  7. Dixon, W. et al. The type, duration, and severity of pretransplant kidney injury predict prolonged kidney dysfunction after liver transplantation. Liver Transpl. 10.1097/LVT.0000000000000386 (2024).
  8. Cullaro, G., Allegretti, A. S., Patidar, K. R., Verna, E. C. & Lai, J. C. Applying metabolomics and aptamer-based proteomics to determine pathophysiologic differences in decompensated cirrhosis patients hospitalized with acute kidney injury. Res. Sq. (2024) doi:10.21203/rs.3.rs-4344179/v1.
  9. Cullaro, G. et al. The association between mean arterial pressure and acute kidney injury reversal among decompensated cirrhosis patients. Hepatology (2024) doi:10.1097/HEP.0000000000000858.
  10. Cullaro, G. et al. Outpatient mean arterial pressure: A potentially modifiable risk for acute kidney injury and death among patients with cirrhosis. Liver Transpl. (2024) doi:10.1097/LVT.0000000000000359.
  11. Allegretti, A. S., Patidar, K. R., Ma, A. T. & Cullaro, G. From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury. Hepatology (2024) doi:10.1097/HEP.0000000000000790.
  12. Przybyszewski, E. M. et al. Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 10–1097 (2024).
  13. Wang, M. et al. Clinical characteristics associated with posttransplant survival among adults 70 years old or older undergoing liver transplantation. J. Clin. Gastroenterol. 58, 516–521 (2024).
  14. Cullaro, G., Ge, J., Lee, B. P., Lai, J. C. & Wadhwani, S. I. Association between neighborhood-based material deprivation and liver transplant waitlist registrants demographics and mortality. Clin. Transplant. e15189 (2023).
  15. Lai, M. et al. Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis. Hepatol Commun 7, (2023).
  16. Wang, M., Wadhwani, S. I., Cullaro, G., Lai, J. C. & Rubin, J. B. Racial and Ethnic Disparities Among Patients Hospitalized for Acute Cholangitis in the United States. J. Clin. Gastroenterol. 57, 731–736 (2023).
  17. Patidar, K. R. et al. Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment. Pharmacol. Ther. 57, 1397–1406 (2023).
  18. Patidar, K. R., Piano, S., Cullaro, G., Belcher, J. M. & Allegretti, A. S. Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective. Clin. Gastroenterol. Hepatol. 21, (2023).
  19. Jo, J. et al. Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant Consortium. Hepatol Commun 7, e2108 (2023).
  20. Postalcioglu, M., Cullaro, G. & Park, M. Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD. Am. J. Kidney Dis. 81, 259–260 (2023).
  21. Cullaro, G. Reply: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis. Hepatology 78, E35-e36 (2023).
  22. Patidar, K. R. et al. Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. (2023) doi:10.1097/lvt.0000000000000241.
  23. Chebrolu, S. et al. Multicenter assessment of hypertension management among liver transplantation recipients. Liver Transpl. 29, 122–124 (2023).
  24. Wang, M., Huang, C. Y., Cullaro, G., Covinsky, K. & Lai, J. C. Women with cirrhosis have lower self-rated health than men. Hepatol Commun 7, e0065 (2023).
  25. Barman, P. M. et al. Predictors of Length of Stay and Mortality During Simultaneous Liver-Kidney Transplant Index Admission: Results From the US-Multicenter SLKT Consortium. Transplant Direct 8, e1408 (2022).
  26. Sharma, P. et al. Burden of early hospitalization after simultaneous liver-kidney transplantation: Results from the US Multicenter SLKT Consortium. Liver Transpl. 28, 1756–1765 (2022).
  27. Cullaro, G., Kanduri, S. R. & Velez, J. C. Q. Acute Kidney Injury in Patients with Liver Disease. Clin. J. Am. Soc. Nephrol. 17, 1674–1684 (2022).
  28. Cullaro, G., Hsu, C.-Y. & Lai, J. C. Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis. Hepatology 76, 1069–1078 (2022).
  29. Cullaro, G., Verna, E. C., McCulloch, C. E. & Lai, J. C. Improving the Model for End-Stage Liver Disease with sodium by incorporating kidney dysfunction types. Hepatology (2022) doi:10.1002/hep.32448.
  30. Lee, B. P. et al. Discordance in categorization of acute-on-chronic liver failure in the United Network for Organ Sharing database. J. Hepatol. 76, 1122–1126 (2022).
  31. Cullaro, G. et al. Temporal Trends and Evolving Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US SLKT Consortium. Liver Transpl. 27, 1613–1622 (2021).
  32. Cullaro, G. & Verna, E. C. Estimating Glomerular Filtration Rate in Cirrhosis: A Variable Science That Needs Clinical Awareness. Liver Transpl. 27, 1525–1526 (2021).
  33. Sharma, P. et al. Renal Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US Multicenter Simultaneous Liver-Kidney Transplantation Consortium. Liver Transpl. 27, 1144–1153 (2021).
  34. Cullaro, G. et al. Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis. Dig. Dis. Sci. (2021) doi:10.1007/s10620-021-07159-z.
  35. Cullaro, G. et al. Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation 105, 2420–2426 (2021).
  36. Cullaro, G. Timing of Acute Kidney Injury Recovery a Promising Indicator of Outcomes After Liver Transplantation. Transplantation Publish Ahead of Print, (2021).
  37. Cullaro, G. et al. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis. Hepatology Communications (2021) doi:10.1002/hep4.1840 PMID - 34676697.
  38. Rubin, J. B., Cullaro, G., Ge, J. & Lai, J. C. Women who undergo liver transplant have longer length of stay post-transplant compared with men. Liver Int. 40, 1725–1735 (2020).
  39. Cullaro, G. & Asrani, S. K. Not All Episodes of Acute Kidney Injury Are Equal in Patients With Cirrhosis, Based on Patterns of Renal Dysfunction. Clin. Gastroenterol. Hepatol. 18, 1694–1695 (2020).
  40. Cullaro, G., Verna, E. C., Lee, B. P. & Lai, J. C. Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post-Liver Transplant Outcomes. Liver Transpl. 26, 498–506 (2020).
  41. Cullaro, G., Sharma, R., Trebicka, J., Cárdenas, A. & Verna, E. C. Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes. Liver Transpl. 26, 283–293 (2020).
  42. Mazumder, N. R. et al. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 104, 242–250 (2020).
  43. Cullaro, G., Rubin, J. B., Mehta, N. & Lai, J. C. Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma. Liver Transpl. 26, 349–358 (2020).
  44. Sheshadri, A., Cullaro, G., Johansen, K. L. & Lai, J. C. Association of Karnofsky Performance Status with waitlist mortality among older and younger adults awaiting kidney transplantation. Clin. Transplant. 34, e13848 (2020).
  45. Cullaro, G. et al. Early Kidney Allograft Failure After Simultaneous Liver-kidney Transplantation (SLKT): Evidence for Utilization of the Safety Net? Transplantation Publish Ahead of Print, (2020).
  46. Cullaro, G., Hirose, R. & Lai, J. C. Changes in Simultaneous Liver-kidney Transplant Allocation Policy May Impact Postliver Transplant Outcomes. Transplantation 103, 959–964 (2019).
  47. Cullaro, G., Verna, E. C. & Lai, J. C. Association Between Renal Function Pattern and Mortality in Patients with Cirrhosis. Clin. Gastroenterol. Hepatol. 17, 2364–2370 (2019).
  48. Lee, B. P., Vittinghoff, E., Dodge, J. L., Cullaro, G. & Terrault, N. A. National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States. JAMA Intern. Med. 179, 340–348 (2019).
  49. Cullaro, G., Park, M. & Lai, J. C. ‘Normal’ Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With Cirrhosis. Hepatology 68, 1953–1960 (2018).
  50. Cullaro, G., Sarkar, M. & Lai, J. C. Sex-based disparities in delisting for being “too sick” for liver transplantation. Am. J. Transplant 18, 1214–1219 (2018).
  51. Cullaro, G., Pisa, J. F., Brown, R. S., Jr, Wagener, G. & Verna, E. C. Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation. Transplantation 102, 809–815 (2018).
  52. Lai, C.-L. et al. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B. J. Hepatol. 66, 275–281 (2017).
  53. Cullaro, G., Kim, G., Pereira, M. R., Brown, R. S. & Verna, E. C. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis. Dig. Dis. Sci. 62, 3487–3494 (2017).
  54. Halilovic, A. et al. Knockdown of heme oxygenase-2 impairs corneal epithelial cell wound healing. J. Cell. Physiol. 226, 1732–1740 (2011).
  55. Patil, K. et al. Heme Oxygenase-1 Induction Attenuates Corneal Inflammation and Accelerates Wound Healing after Epithelial Injury. Invest. Ophthalmol. Vis. Sci. 49, 3379–3386 (2008).